Merck breaks ground on new $1 billion Biologics Center of Excellence in Delaware, US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
This unit will focus on the manufacturing of health and wellness equipment
The plant will have installed production capacity of 3,120 MT/month
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Subscribe To Our Newsletter & Stay Updated